Betamethasone-17-benzoate in the treatment of recurrent aphthous ulcers.
A double-blind study of the effectiveness of betamethasone-17-benzoate in the treatment of recurrent aphothous ulcers (RAU) was concucted. The drug was found to be effective in reducing symptoms and shortening healing time but not in preventing recurrences. Evaluation of the medical histories and laboratory studies suggests that multiple factors may be involved in the etiology of RAU, as reported by others.
D001565:Benzoates / Q000627:therapeutic use; D001623:Betamethasone / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D005782:Gels; D006801:Humans; D008297:Male; D010919:Placebos; D012008:Recurrence; D013281:Stomatitis, Aphthous / Q000188:drug therapy* / Q000503:physiopathology; D013997:Time Factors; D014945:Wound Healing
D001565:Benzoates; D005782:Gels; D010919:Placebos; D001623:Betamethasone